Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04070209
Title Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sir Mortimer B. Davis - Jewish General Hospital
Indications

prostate adenocarcinoma

Therapies

Darolutamide

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.